Rimonabant for Canadians
It’s easy to get fed up with diets and diet medications that don’t work Even if they do work, all the weight that you lose always comes back again anyways; and these diet drugs can be very expensive and can also cause side effects!
Thankfully, dieters now have an effective medication on their side. Rimonabant, the active ingredient in Acomplia, is the first clinically proven medication that really helps overweight people lose weight…and keep it off!
Rimonabant was developed through exhaustive research and clinical trials by the French pharmaceutical company Sanofi-Aventis. This new wonder medication works by blocking the CB-1 receptors in the body. These CB-1 receptors are responsible for controlling appetite and food cravings. The CB-1 receptor is found in the brain as well as in the lipid cells of the body, and is linked with fat metabolism. By blocking these receptors, overweight people will feel less hungry and will be more likely to follow a healthy reduced calorie dietary plan.
Rimonabant can also help you quit smoking as the CB-1 receptors are also responsible for your cravings for nicotine. This drug will improve the cardiovascular and metabolic health of acceptable candidates.
Rimonabant is taken as one 20 mg pill daily before breakfast with a full glass of water. Clinical trials indicate that when taken in conjunction with a calorie reduced healthy diet and moderate exercise, dramatic weight loss will occur.
Rimonabant is not suitable for pregnant women and breast feeding mothers. Make certain that you discuss both your medical history as well as all medications that you are taking with your doctor before taking Acomplia.
Clinical studies have proven the drug quite safe. A small percentage of people report minor side effects such as vomiting, irritability, anxiety, muscle cramps and dizziness. These side effects will normally reduce in severity and eventually disappear as your body becomes more accustomed to the drug. If you do not notice a reduction in side effect severity over time, discuss the medication again with your doctor. If you experience any sever side effects, seek medical attention immediately.
Canadian Approval for Rimonabant
Rimonabant is not yet available for sale in Canada, although it is anticipated to be available by prescription next year. The Canadian drug approval system operates more slowly than FDA approval mechanisms, and the drug has not yet been submitted for Canadian evaluation by the French drug maker.